TENET Innovation to Commercialization (i2c) Program 

The TENET i2c program is open to University of Calgary researchers, clinicians, postdocs, graduate students, and staff across all faculties interested in transforming their health-related research into a commercial product.  

To be eligible, applicants must meet the following criteria:  

• Have developed a commercially viable research project related to the health field  

• Translation of research into a commercial product or service must be carried out in the province of Alberta  

• The principal applicant must be a founding member and currently affiliated with the University of Calgary (i.e., faculty member, trainee or staff) 

• All applicants must have an undergraduate degree (minimum)  

• Applicants must be able to participate in pitch training schedule and workshops. 

• Applicants have not previously participated in TENET i2c and/or REHAB i2c programs. 

Some of the benefits of the program that participants can expect include: 

• Transform your health research into an impactful commercial product or service 

• Receive entrepreneurial training, coaching and resources from the Hunter Hub

• Get matched with mentors from the greater innovation community 

• Enhance your knowledge and skills before pitching your venture at a final competition 

• Win up to $100,000 to commercialize your product 

• Read the 2021 winners announcement in UToday

• Read the 2020 winners announcement in UToday

• Read the 2019 winners announcement in UToday  

• Read the 2018 winners announcement in UToday 

• Read the 2017 winners announcement in UToday 

• Read the 2016 winners announcement in UToday 

The TENET i2c program became possible thanks to a generous donation from Ken Moore, former president of TENET Biomedical Engineering (1994-2011).  
  
Before TENET Biomedical Engineering, Moore played professional football with the Calgary Stampeders and Saskatchewan Roughriders from 1983 to 1994, winning two Grey Cups. During the final year of his football career, he enrolled in graduate studies at the Cumming School of Medicine under the supervision of Dr. Cy Frank and Nigel Shrive, PhD, members of the McCaig Institute for Bone and Joint Health. It was there that Moore joined a research group that founded TENET Medical Engineering. The company grew from a basic startup to the global leader in the positioning of arthroscopic shoulder surgery, with more than $30 million in annual sales to over 50 countries around the world.  
  
After the sale of TENET Medical Engineering in 2011, Moore returned to the University of Calgary with a generous donation that supported scholarships, educational opportunities, and an annual pitch competition – TENET i2c. Moore sees the societal need and value in facilitating innovative solutions to address simple and complex medical problems. The TENET i2c competition demonstrates his generosity and passion for seeing young startup companies receive a “boost-start” to get their products and services to market.  
  
In its early years, the program was exclusive to ventures within the Cumming School of Medicine. After an expansion, today TENET i2c encourages participants from all faculties to apply for a chance to build their health-related research into reality. 

Questions? Contact the Hunter Hub for Entrepreneurial Thinking by email at [email protected], or by phone: 403.220.4425. 

The TENET i2c Competition will be held on June 3, 2022, during Inventures.